Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of Hypertrophic Cardiomyopathy
Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of Hypertrophic Cardiomyopathy is organized by AcademicCME.
Program Dates: May 19, 2023 - May 18, 2024
Program Overview:
This CME program, derived from content presented at the European Association of Cardiovascular Imaging Annual Congress EACVI 2023 in Barcelona, Spain, will highlight how to optimize echocardiographic and CMR assessment in the diagnosis and management of hypertrophic cardiomyopathy. In hypertrophic cardiomyopathy, multimodality imaging is crucial to confirm diagnosis, assess for presence and mechanism of left ventricular outflow tract obstruction, and risk stratification for sudden cardiac death. Comfort with echocardiographic techniques to optimize visualization and with cardiac MRI as indicated and as available is required to make best utilization of new therapies for HCM. Our expert faculty will review both research-oriented and practice-pertinent information on the best use of imaging in the contemporary diagnosis and management of HCM.
Learning Objectives:
• Deeper familiarity and comfort with the clinical interpretation of appropriately performed cardiac imaging studies (echocardiography and CMR) in patients with or at risk for HCM
• An improved understanding of the prevalence, pathophysiology, unmet patient needs, and natural course of HCM
• Operational confidence in recognizing the indications to treat, longitudinally manage, and/or refer to subspecialists, patients diagnosed with HCM
• Awareness and understanding of the clinical trial data evaluating the efficacy and safety of new and emerging treatment options for HCM
Additional details will be posted as soon as information is available.